Privia Health Group, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $22.9M | $14.4M | $23.1M | $-8.6M | $-188.2M | $31.2M | $8.2M |
| Depreciation & Amortization | $9.9M | $7.3M | $6.5M | $4.6M | $2.5M | $1.8M | $1.4M |
| Depreciation | $739.0K | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M | $784.0K |
| Amortization | $9.2M | $6.2M | $5.4M | $3.4M | $1.3M | $642.0K | $643.0K |
| Stock-Based Compensation | $71.1M | $56.7M | $37.1M | $67.4M | $253.5M | $484.0K | $207.0K |
| Net Cash from Operating Activities | $163.4M | $109.3M | $80.8M | $47.2M | $55.1M | $38.9M | $24.4M |
| Investing Activities | |||||||
| Capital Expenditures | — | — | $113.0K | $104.0K | $547.0K | $380.0K | $5.7M |
| Business Acquisitions | $180.4M | $7.0M | $42.9M | $0 | $32.2M | $0 | $0 |
| Net Cash from Investing Activities | $-181.6M | $-12.0M | $-43.0M | $-104.0K | $-32.8M | $-380.0K | $-5.7M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $6.7M | $4.3M | $3.7M | $-19.7M | $213.7M | $-767.0K | $-10.9M |
| Net Change in Cash | $-11.5M | $101.6M | $41.5M | $27.4M | $235.9M | $37.7M | $7.8M |
| Free Cash Flow | — | — | $80.7M | $47.1M | $54.5M | $38.5M | $18.6M |